» Articles » PMID: 20364087

IL-17 is Essential for Host Defense Against Cutaneous Staphylococcus Aureus Infection in Mice

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2010 Apr 6
PMID 20364087
Citations 348
Authors
Affiliations
Soon will be listed here.
Abstract

Staphylococcus aureus is the most common cause of skin and soft tissue infections, and rapidly emerging antibiotic-resistant strains are creating a serious public health concern. If immune-based therapies are to be an alternative to antibiotics, greater understanding is needed of the protective immune response against S. aureus infection in the skin. Although neutrophil recruitment is required for immunity against S. aureus, a role for T cells has been suggested. Here, we used a mouse model of S. aureus cutaneous infection to investigate the contribution of T cells to host defense. We found that mice deficient in gammadelta but not alphabeta T cells had substantially larger skin lesions with higher bacterial counts and impaired neutrophil recruitment compared with WT mice. This neutrophil recruitment was dependent upon epidermal Vgamma5+ gammadelta T cell production of IL-17, but not IL-21 and IL-22. Furthermore, IL-17 induction required IL-1, TLR2, and IL-23 and was critical for host defense, since IL-17R-deficient mice had a phenotype similar to that of gammadelta T cell-deficient mice. Importantly, gammadelta T cell-deficient mice inoculated with S. aureus and treated with a single dose of recombinant IL-17 had lesion sizes and bacterial counts resembling those of WT mice, demonstrating that IL-17 could restore the impaired immunity in these mice. Our study defines what we believe to be a novel role for IL-17-producing epidermal gammadelta T cells in innate immunity against S. aureus cutaneous infection.

Citing Articles

Antifungal immunity: advances in PRR recognition, adaptive responses, and immune-based therapies.

Zhou J, Lu X, He R, Du Y, Zeng B, Feng L Sci China Life Sci. 2025; .

PMID: 40055278 DOI: 10.1007/s11427-024-2835-y.


in Inflammation and Pain: Update on Pathologic Mechanisms.

Rasquel-Oliveira F, Ribeiro J, Martelossi-Cebinelli G, Costa F, Nakazato G, Casagrande R Pathogens. 2025; 14(2).

PMID: 40005560 PMC: 11858194. DOI: 10.3390/pathogens14020185.


-specific TIGIT Treg are present in the blood of healthy subjects - a hurdle for vaccination?.

Clegg J, Mnich M, Carignano A, Cova G, Tavarini S, Sammicheli C Front Immunol. 2025; 15:1500696.

PMID: 39981298 PMC: 11840346. DOI: 10.3389/fimmu.2024.1500696.


Early cytokine signatures and clinical phenotypes discriminate persistent from resolving MRSA bacteremia.

Bergersen K, Zheng Y, Rossetti M, Ruffin F, Pickering H, Parmar R BMC Infect Dis. 2025; 25(1):231.

PMID: 39966757 PMC: 11834594. DOI: 10.1186/s12879-025-10620-3.


Roles of dendritic epidermal T cells in steady and different pathological states.

Hao J, Zhang J, Liu Y Burns Trauma. 2025; 13:tkae056.

PMID: 39944225 PMC: 11814495. DOI: 10.1093/burnst/tkae056.


References
1.
Caruso R, Botti E, Sarra M, Esposito M, Stolfi C, Diluvio L . Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis. Nat Med. 2009; 15(9):1013-5. DOI: 10.1038/nm.1995. View

2.
Duhen T, Geiger R, Jarrossay D, Lanzavecchia A, Sallusto F . Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol. 2009; 10(8):857-63. DOI: 10.1038/ni.1767. View

3.
Trifari S, Kaplan C, Tran E, Crellin N, Spits H . Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat Immunol. 2009; 10(8):864-71. DOI: 10.1038/ni.1770. View

4.
McLoughlin R, Lee J, Kasper D, Tzianabos A . IFN-gamma regulated chemokine production determines the outcome of Staphylococcus aureus infection. J Immunol. 2008; 181(2):1323-32. DOI: 10.4049/jimmunol.181.2.1323. View

5.
Priebe G, Walsh R, Cederroth T, Kamei A, Coutinho-Sledge Y, Goldberg J . IL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa. J Immunol. 2008; 181(7):4965-75. PMC: 2597098. DOI: 10.4049/jimmunol.181.7.4965. View